Member Info for Chazzy2

It's ok Jesterman I've just spotted that Pam Martin is with Selftrade. Yes I will certainly contact her if there is no resolution soon. There is another lady from Selftrade who I'm liaising with also at the moment who is trying to resolve the issue, but I might well take this matter to the top if it's not sorted out soon.

Hi Jesterman, thanks for your reply. Is Pam Martin the Customer Services Centre Manager of Selftrade or Portage? Have you experienced any problems in receiving the share certificates yourself? I just wondered how you know who to contact. Thanks again.

I'd be interested to know of any other SALV shareholders who have not yet received their Portage shares, particularly any who use Selftrade. I've contacted Selftrade several times as well as emailed Portage for some clarification. Portage have told me that the share certificates were dispatched back in Jan, but Selftrade's nominees have confirmed that the certificates never arrived, hence lost in transit apparently!! If this is true it's clearly very concerning. I'm still waiting for further clarification.
If you haven't yet received your share certificate, I would strongly recommend you contact your broker too and confirm whether your nominees have actually received the shares from the Portage Registrars in Canada.
Would appreciate any comments on this.

Chilston, when was the last time you posted a link of interest to FFWD shareholders, or for that matter anything remotely interesting or useful? No.. I can't find it either!

Forward 15 mins for Paul Snow. There's even a brief mention of Yooya after 59 mins, so at least we know Yooya hasn't disappeared entirely into a black hole!

update by Paul Snow. Not sure whether this has been posted or not.

https://www.youtube.com/watch?v=0KY1bQGFmd0

http://www.pharmatimes.com/news/insilico,_ark_initiate_health-span_and_longevity_partnership_1288969

If the link won't open just google insilico and you'll find it anyway.

http://www.pharmatimes.com/news/insilico,_ark_initiate_health-span_and_longevity_partnership_1288969

For me the consideration of whether to hold Leap boils down to how much more mileage we can get from it. Being our largest stake by far it would be worth holding if the % returns over the next couple of years are as good as we can expect from other investments, but I suspect the growth momentum won't be as good as with a life science investment. I would be disappointed if we got anything less than £10 million for Leap.

Blue is the colour, Leap is the game, we're all waiting patiently, and winning is our aim.

Nice find Mat. Just the tonic investors need right now. Germany the biggest market in Europe.

I think we should see the RNS as a positive. Yes we may have made a small loss on the partial sale of Vemo, but then the adoption of ISAs in the US was always going to be a slow burner. How many universities in the US have actually adopted Vemo's solution? Not that many to date. On the other hand if they reinvest the money into another medical cannabis company the returns could be substantially higher over the short term. Medical cannabis is a very hot industry at present and several private medical cannabis companies are considering IPOs soon. Emmac alone could net us a 5 bag return when it IPOs, and so others could also. I imagine the board have weighed it up carefully in taking this decision.

...better watch out, better beware, Albert says E = mc2, Einstein Vogogo....

Yes, great article. It really illustrates FFWD's approach of looking for the very best companies in some of the fastest growing industries, led by the most talented in those industries. Emmac will be a multibillion company within a few years.

https://www.youtube.com/watch?v=ZJsozu5eIHs

Another one worth listening too. Slightly longer this time but really worth it!

https://www.youtube.com/watch?v=p9LU7aLdc-k

For all you doubters, have a listen to this!

https://www.youtube.com/watch?v=HydF9UhKXN8

For anyone interested who didn't attend the MI show.

https://www.globallegalchronicle.com/emmac-life-sciences-acquisition-of-leading-swiss-wellness-cbd-company-blossom/

Yes sure M'Lord. We all hope the board can pull off another Aphria in the near term. We may see it in Emmac as we know they are planning a float. Leap must be worth a bob or two now. Let's not forget they were nearly bought out two years ago which would have netted us $6 m, and that was before they started doing deals with global giants such as IMG. Our stake in Leap alone now must be worth our current market cap. We'll see!

I don't think anyone is suggesting that we are going to be stuck at these levels indefinitely as news could come out any time for any of the investments, but it's just that we need to be realistic and appreciate that this is a medium to long term investment. The investments we hold all have multi-bag potential, but because they nearly all start as private small companies they can take in some cases years before we see that multi-bag growth. Amongst the bio/medical companies value inflexion points in the near term which we know of are: Intensity phase1/2 trials completion next year, Juvenescence IPO next year, Emmac IPO soon. These three alone will be transformational to the FFWD share price. The other companies we can only speculate as to whether an IPO/sale will occur within the next few months, but we do know that companies like Factom, Leap, Vemo, Yooya are all growing at extraordinary rates, so when their time comes we will know about it! Patience is required in the meantime.